EUVIMEDOpdag EUVIMED
Crossref

Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer

The Internet Journal of Oncology · 2006

DOI: 10.5580/1752 ↗

At a glance

Journal article in The Internet Journal of Oncology, 2006.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.

Cite

APA

(2006). Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. https://doi.org/10.5580/1752

Vancouver

Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. 2006. doi:10.5580/1752

BibTeX
@article{euvimed2006,
  title = {Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer},
  journal = {The Internet Journal of Oncology},
  year = {2006},
  doi = {10.5580/1752}
}
Start for free →